Journal
PHYTOTHERAPY RESEARCH
Volume 35, Issue 12, Pages 6720-6734Publisher
WILEY
DOI: 10.1002/ptr.7258
Keywords
cancer; IL-6; malignant tumor; phenolic compounds
Categories
Funding
- National Natural Science Foundation of China [81973677]
Ask authors/readers for more resources
Cytokine therapy, focusing on the regulation of IL-6, shows potential as a novel approach in cancer treatment, but more high-quality clinical studies are needed to validate its efficacy.
Cytokine therapy, which activates the host immune system, has become an important and novel therapeutic approach to treat various cancers. Recent studies have shown that IL-6 is an important cytokine that regulates the homeostasis in vivo. However, excessive IL-6 plays a pathological role in a variety of acute and chronic inflammatory diseases, especially in cancer. IL-6 can transmit signals through JAK/STAT, RAS /MAPK, PI3K/ Akt, NF-kappa B, and other pathways to promote cancer progression. Phenolic compounds can effectively regulate the level of IL-6 in tumor cells and improve the tumor microenvironment. This article focuses on the phenolic compounds through the regulation of IL-6, participate in the prevention of cancer, inhibit the proliferation of cancer cells, reduce angiogenesis, improve therapeutic efficacy, and reduce side effects and other aspects. This will help to further advance research on cytokine therapy to reduce the burden of cancer and improve patient prognosis. However, current studies are mostly limited to animal and cellular experiments, and high-quality clinical studies are needed to further determine their antitumor efficacy in humans.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available